These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

887 related articles for article (PubMed ID: 31906988)

  • 41. Connectivity Between Salience and Default Mode Networks and Subcortical Nodes Distinguishes Between Two Classes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Su J; Thapaliya K; Eaton-Fitch N; Marshall-Gradisnik S; Barnden L
    Brain Connect; 2023 Apr; 13(3):164-173. PubMed ID: 36352819
    [No Abstract]   [Full Text] [Related]  

  • 42. A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Johnston S; Staines D; Klein A; Marshall-Gradisnik S
    BMC Med Genet; 2016 Nov; 17(1):79. PubMed ID: 27835969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
    Gómez-Mora E; Carrillo J; Urrea V; Rigau J; Alegre J; Cabrera C; Oltra E; Castro-Marrero J; Blanco J
    Front Immunol; 2020; 11():582330. PubMed ID: 33329554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Skin Temperature Circadian Rhythms and Dysautonomia in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Role of Endothelin-1 in the Vascular Tone Dysregulation.
    Cambras T; Zerón-Rugerio MF; Díez-Noguera A; Zaragozá MC; Domingo JC; Sanmartin-Sentañes R; Alegre-Martin J; Castro-Marrero J
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review.
    Maksoud R; Magawa C; Eaton-Fitch N; Thapaliya K; Marshall-Gradisnik S
    BMC Med; 2023 May; 21(1):189. PubMed ID: 37226227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Major Depressive Disorder and Chronic Fatigue Syndrome Show Characteristic Heart Rate Variability Profiles Reflecting Autonomic Dysregulations: Differentiation by Linear Discriminant Analysis.
    Shinba T; Kuratsune D; Shinba S; Shinba Y; Sun G; Matsui T; Kuratsune H
    Sensors (Basel); 2023 Jun; 23(11):. PubMed ID: 37300057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychometric properties of the PROMIS
    Yang M; Keller S; Lin JS
    Qual Life Res; 2019 Dec; 28(12):3375-3384. PubMed ID: 31506915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fatigue and symptom-based clusters in post COVID-19 patients: a multicentre, prospective, observational cohort study.
    Cornelissen MEB; Bloemsma LD; Vaes AW; Baalbaki N; Deng Q; Beijers RJHCG; Noij LCE; Houweling L; Bazdar S; Spruit MA; Maitland-van der Zee AH;
    J Transl Med; 2024 Feb; 22(1):191. PubMed ID: 38383493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contrasting case definitions for chronic fatigue syndrome, Myalgic Encephalomyelitis/chronic fatigue syndrome and myalgic encephalomyelitis.
    Jason LA; Brown A; Clyne E; Bartgis L; Evans M; Brown M
    Eval Health Prof; 2012 Sep; 35(3):280-304. PubMed ID: 22158691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Nagy-Szakal D; Williams BL; Mishra N; Che X; Lee B; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Ramanan D; Jain K; Eddy ML; Hornig M; Lipkin WI
    Microbiome; 2017 Apr; 5(1):44. PubMed ID: 28441964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial.
    Cash A; Kaufman DL
    J Transl Med; 2022 Jun; 20(1):295. PubMed ID: 35764955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Natural killer cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a multi-site clinical assessment of ME/CFS (MCAM) sub-study.
    Querec TD; Lin JS; Chen Y; Helton B; Kogelnik AM; Klimas NG; Peterson DL; Bateman L; Lapp C; Podell RN; Natelson BH; Unger ER;
    J Transl Med; 2023 Apr; 21(1):242. PubMed ID: 37013608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
    Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
    J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impaired blood pressure variability in chronic fatigue syndrome--a potential biomarker.
    Frith J; Zalewski P; Klawe JJ; Pairman J; Bitner A; Tafil-Klawe M; Newton JL
    QJM; 2012 Sep; 105(9):831-8. PubMed ID: 22670061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
    Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M
    J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolomic Evidence for Peroxisomal Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Che X; Brydges CR; Yu Y; Price A; Joshi S; Roy A; Lee B; Barupal DK; Cheng A; Palmer DM; Levine S; Peterson DL; Vernon SD; Bateman L; Hornig M; Montoya JG; Komaroff AL; Fiehn O; Lipkin WI
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Submaximal exercise testing with near-infrared spectroscopy in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients compared to healthy controls: a case-control study.
    Miller RR; Reid WD; Mattman A; Yamabayashi C; Steiner T; Parker S; Gardy J; Tang P; Patrick DM
    J Transl Med; 2015 May; 13():159. PubMed ID: 25990639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms.
    Nkiliza A; Parks M; Cseresznye A; Oberlin S; Evans JE; Darcey T; Aenlle K; Niedospial D; Mullan M; Crawford F; Klimas N; Abdullah L
    J Transl Med; 2021 Aug; 19(1):370. PubMed ID: 34454515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.